Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study

被引：5
|
作者：
Qiang, Judy K. [1 ]
Shahbaz, Ali [2 ]
Kim, Whan [3 ]
Marinas, Joseph [3 ]
Greaves, Simon [4 ]
Yeung, Jensen [5 ]
机构：
[1] Univ Toronto, Fac Med, Toronto, ON M5S 1B2, Canada
[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada
[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada
[5] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 01期
关键词：
TO-SEVERE PSORIASIS; ETANERCEPT; EFFICACY;
D O I：
10.1016/j.jaad.2015.08.030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：176 / 177
页数：3
相关论文
共 50 条
  • [41] Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study
    Colombo, Delia
    Bianchi, Luca
    Fabbrocini, Gabriella
    Corrao, Salvatore
    Offidani, Annamaria
    Stingeni, Luca
    Costanzo, Antonio
    Pellacani, Giovanni
    Peris, Ketty
    Bardazzi, Federico
    Argenziano, Giuseppe
    Ruffolo, Silvana
    Dapavo, Paolo
    Carrera, Carlo
    Fargnoli, Maria Concetta
    Parodi, Aurora
    Romanelli, Marco
    Malagoli, Piergiorgio
    Talamonti, Marina
    Megna, Matteo
    Raspanti, Massimo
    Paolinelli, Matteo
    Hansel, Katharina
    Narcisi, Alessandra
    Conti, Andrea
    De Simone, Clara
    Chessa, Marco Adriano
    De Rosa, Alina
    Provenzano, Eugenio
    Ortoncelli, Michela
    Moltrasio, Chiara
    Fidanza, Rosaria
    Burlando, Martina
    Tonini, Annalisa
    Gaiani, Francesca Maria
    Simoni, Lucia
    Ori, Alessandra
    Fiocchi, Martina
    Zagni, Emanuela
    DERMATOLOGIC THERAPY, 2022, 35 (01)
  • [42] Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian
    Shahbaz, A.
    Qiang, J.
    Marinas, J. E. C.
    Kim, W. B.
    Greaves, S.
    Yeung, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (01) : 297 - 298
  • [43] Real-world effectiveness of tildrakizumab in a Phase 4 study in patients with moderate-to- severe plaque psoriasis
    Bhatia, Neal
    Vasquez, J. Gabriel
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB216 - AB216
  • [44] Effectiveness, safety and survival of guselkumab in patients with moderate-to-severe psoriasis after 156 weeks, in real clinical practice
    Fernandez-Freire, Lourdes Rodriguez
    Ruiz Villaverde, Ricardo
    Armario Hita, Jose Carlos
    Perez Gil, Amalia
    Vasquez Chinchay, Fiorella
    Moreno Suarez, Fatima
    Martinez Pilar, Leandro
    Galan Gutierrez, Manuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB154 - AB154
  • [45] Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice
    Bohinc, Masa
    Branisteanu, Daciana Elena
    Khobzey, Kuzma
    Kingo, Kulli
    Pavlovsky, Lev
    Pec, Juraj
    Szegedi, Andrea
    Miljkovic, Jovan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S33 - S33
  • [46] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [47] Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study
    Chiricozzi, Andrea
    Gori, Niccolo
    Narcisi, Alessandra
    Balato, Anna
    Gambardella, Alessio
    Ortoncelli, Michela
    Marzano, Angelo Valerio
    Balestri, Riccardo
    Palazzo, Giovanni
    Pellegrino, Michele
    Romanelli, Marco
    Tripepi, Giovanni
    Peris, Ketty
    Costanzo, Antonio
    DRUGS IN R&D, 2022, 22 (03) : 245 - 252
  • [48] Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study
    Andrea Chiricozzi
    Niccolò Gori
    Alessandra Narcisi
    Anna Balato
    Alessio Gambardella
    Michela Ortoncelli
    Angelo Valerio Marzano
    Riccardo Balestri
    Giovanni Palazzo
    Michele Pellegrino
    Marco Romanelli
    Giovanni Tripepi
    Ketty Peris
    Antonio Costanzo
    Drugs in R&D, 2022, 22 : 245 - 252
  • [49] Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
    Kim, Dong Hyun
    Son, Sang Wook
    Jeong, Ki-Heon
    Ahn, Jiyoung
    Lee, Eun-So
    Kim, Il-Hwan
    Ha Lee, Un
    Park, Hai-Jin
    Ko, Joo Yeon
    Kim, Byung-Soo
    Kim, Jin Ju
    Rashid, Javed
    Kim, Kwang Joong
    ANNALS OF DERMATOLOGY, 2023, 35 (02) : 107 - 115
  • [50] Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
    Lynde, Charles
    Riedl, Elisabeth
    Maul, Julia-Tatjana
    Torres, Tiago
    Pinter, Andreas
    Fabbrocini, Gabrielle
    Daniele, Flavia
    Brnabic, Alan
    Reed, Catherine
    Wilhelm, Stefan
    Holzkamper, Thorsten
    Schuster, Christopher
    Puig, Luis
    ADVANCES IN THERAPY, 2023, 40 (03) : 869 - 886
12345